期刊文献+

表没食子儿茶素没食子酸酯对APP/PS1转基因小鼠海马IRS-1磷酸化的影响 被引量:1

The impact of epigallocatechin-3-gallate(EGCG)on expression of the phosphorylation of IRS-1 in the hippocampus of APP/PS1 transgenetic mice
原文传递
导出
摘要 目的:观察表没食子儿茶素没食子酸酯(EGCG)对APP/PS1转基因小鼠海马胰岛素受体底物-1(IRS-1)磷酸化的作用。方法:12月龄雌性APP/PS1小鼠随机分为模型组(Tg)、EGCG低剂量组(Tg/EGCG-L)、高剂量组(Tg/EGCG-H),同月龄雌性C57BL/6J小鼠作为对照组(NT)。采用Western blot和免疫组织化学方法检测各组小鼠海马IRS-1pSer636的表达。结果:与对照组比较,模型组小鼠海马IRS-1pSer636表达明显升高(P<0.05),EGCG各治疗组IRS-1pSer636表达较模型组降低(P<0.05)。结论:EGCG可以减轻APP/PS1小鼠海马胰岛素抵抗,其机制可能部分与减轻IRS-1在丝氨酸636位点的磷酸化水平有关。 OBJECTIVE To observe the effects of epigallocatechin-3 gallate (EGCG) on the expression of insulin receptor substrate-l(IRS-1) phosphorylation in the hippocampus of APP/PS1 transgenetie mice. METHODS 12 months old female APP/PS1 mice were randomly divided into 3 groups: model group(Tg), EC, CG low dose group (Tg /EGCC-L), high dose group(Tg/EGCG-H). C57BL/6J mice were utilized as control. The hippocampal IRS-lpSer636 level of each group was detected by Western blot and Immunohistochemical staining. RESULTS Compared with NT mice, the hippocampal IRS-lpSer636 level of Tg mice was increased significantly (P〈0. 05), Tg/EGCG-L and Tg/EGCG-H mice showed an obvious decrease of IRS-lpSer636 level in the hippocampus compared with Tg mice(P〈0. 05). CONCLUSION EGCG treatment is able to alleviate insulin resistance in the hippocampus of APP/PS1 mice, which may be partly attributed to the reduction of IRS-1pSer636 level in this mice model.
作者 贾宁 韩锟
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2014年第13期1072-1075,共4页 Chinese Journal of Hospital Pharmacy
基金 辽宁省科学技术计划项目(编号:2012225019) 辽宁省自然科学基金项目(编号:2013022028)
关键词 表没食子儿茶素没食子酸酯 APP PS1转基因小鼠 胰岛素受体底物-1 epigallocatechin-3-gallate APP/PS1 transgenetic mice insulin receptor substrate-1
  • 相关文献

参考文献7

  • 1de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease[J]. Curr Alzheimer Res, 2012, 9: 35-66.
  • 2Talbot K, Wang HY, Kazi H, et al. Demonstrated brain in sulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline[J]. J Clin Invest, 21)12, 122:1316-1338.
  • 3Zhang ZF, Li Q,Liang J, et al. Epigallocatechin 3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition [J]. Phytomedicine,2010, 17: 14-18.
  • 4Li Y, Zhao S, Zhang W, et al. Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo [J]. Diabetes Res Clin Pract, 2011, 93: 205-214.
  • 5Koh SH, Lee SM, Kim HY, et al. The effect of epigallocate- chin gallate on suppressing disease progression of ALSmodel mice[J]. Neurosci Lett, 2006, 395(2) : 103-107.
  • 6Ghasemi R, Dargahi L, Haeri A, etal. Brain insulin dysregu- latiomimplication for neurological and neuropsychiatric disor- ders[J]. Mol Neurobiol, 2013, 47(3):1045-1065.
  • 7Bomfim TR, Forny-Germano L, Sathler LB,et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers[J]. J Clin Invest, 2012, 122: 1339-1353.

同被引文献26

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部